Genmab stockGMAB
Genmab trades at $52.74, 12.1% below its 52-week high (Oct 28, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +71.2% year to date, +80.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for GMAB — after you log in
Open the terminalFrequently asked questions about Genmab
What is the Genmab stock price?
At the close on Nov 5, 2026: $52.74 (−4.32% on the day). 52-week high: $59.97 on Oct 28, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Genmab report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed −9% year over year, revenue +25%.
Does Genmab pay dividends?
No, Genmab does not pay dividends.
Where does Genmab trade and how to buy it?
Ticker GMAB, exchange Nasdaq, listed since 2019. You can buy it through a broker with access to US exchanges.
Should I buy Genmab now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for GMAB are in the terminal after you log in.